Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

2010 launch of Devgen's nematicide "Enclosure" in the United Statesqrcode

May. 11, 2009

Favorites Print
May. 11, 2009

Devgen's nematicide  product   obtained regulatory approval in the  US and will be  promoted under the  brand name Enclosure. First year sales  will focus on Enclosure usage  in peanuts. The USDA has estimated  the annual economic loss in  peanuts caused by nematodes at 12%. Peanuts are an important global commodity with an  average US  annual production  well above  4 billion  pounds (about 1.8  billion kg)  and a  value  of 800  million USD  (EUR  600 million).

US peanut trials conducted by  Devgen have demonstrated that the  use of its  nematicide  reduces  nematode  damage  and  increases  peanut quality  and  yield.  In  preparation  for  2010  sales,  Devgen   is conducting large  demonstration  trials for  growers,  besides  extra university/extension reference trials.

Enclosure is based on the active ingredient Iprodione. The discovery of Iprodione  for  use as  a  nematicide (patent  pending)  was  made through   Devgen's   proprietary   genomic-based   crop    protection technology. The  product  has  been  under  development  in  multiple countries by Devgen for the past 5 years.

Thierry Bogaert,  CEO of  Devgen says:  "Devgen is  pleased to  offer farmers a new solution  to protect their crops  from nematodes in  an environment where  the options  to treat  against this  serious  pest become more and more restricted."

Source: PR-Inside

Picture 0/1200

More from AgroNews


2020 India Pesticide Suppliers Guide 2020 Market Insight
2020 CRO & CRAO Manual 2020 Biologicals Special
2020 Latin America Focus 2020 Formulation & Adjuvant Technology
Subscribe Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.